Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 7/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 2/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6103610 | 0.90 | FDPS (0.44) | FDPSTGFBR1 | |
| SCHEMBL4184803 | 0.87 | FDPS (0.47) | FDPS | |
| SCHEMBL1409013 | 0.85 | TGFBR1 (0.43) | FDPSTGFBR1CA12CA1CA2 | |
| SCHEMBL2552690 | 0.79 | TGFBR1 (0.39) | FDPSTGFBR1METAP1TAS1R3TAS1R1 | |
| SCHEMBL15032661 | 0.76 | TGFBR1 (0.42) | TGFBR1CA12CA1CA2MMP1 | |
| SCHEMBL337892 | 0.75 | TSHR (0.44) | FDPSMETAP1TAS1R3TAS1R1CA12 | |
| SCHEMBL1826412 | 0.75 | TGFBR1 (0.47) | TGFBR1TAS1R3TAS1R1 | |
| SCHEMBL976101 | 0.75 | TGFBR1 (0.42) | TGFBR1CA12CA1CA2MMP1 | |
| SCHEMBL10909470 | 0.75 | TGFBR1 (0.47) | TGFBR1TAS1R3TAS1R1 | |
| SCHEMBL28829839 | 0.74 | TGFBR1 (0.43) | TGFBR1TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8835675-B2 | Polymerizable phosphonic acid derivative and adhesive composition comprising the same | KABUSHIKI KAISHA SHOFU (JP) | 2014-09-16 | — | — | US | disclosed |
| US-20090048426-A1 | POLYMERIZABLE PHOSPHONIC ACID DERIVATIVE AND ADHESIVE COMPOSITION COMPRISING THE SAME | KABUSHIKI KAISHA SHOFU (JP) | 2009-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090048426-A1 | POLYMERIZABLE PHOSPHONIC ACID DERIVATIVE AND ADHESIVE COMPOSITION COMPRISING THE SAME | PTK2, ITGA1, ACTN1 | FDPS 2479/4885TGFBR1 1552/4885METAP1 490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.